Clinical Trial Update: A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating omalizumab for prevention of allergen-induced airway obstruction in adults with mild allergic asthma completed; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Allergic Asthma | Phase 2 | Status: COMPLETED | Results posted: 2010-05-26